Exploring the Long-Term Safety of Asenapine in Adults With Schizophrenia in a Double-Blind, Fixed-Dose, Extension Study

Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s130211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search